Laboratory Abnormalities in CKD-MBD: Markers, Predictors, or Mediators of Disease?
- 1 March 2014
- journal article
- review article
- Published by Elsevier in Seminars in Nephrology
- Vol. 34 (2) , 151-163
Abstract
No abstract availableKeywords
This publication has 133 references indexed in Scilit:
- Update on fibroblast growth factor 23 in chronic kidney diseaseKidney International, 2012
- The serum 24,25-dihydroxyvitamin D concentration, a marker of vitamin D catabolism, is reduced in chronic kidney diseaseKidney International, 2012
- Calcium balance in normal individuals and in patients with chronic kidney disease on low- and high-calcium dietsKidney International, 2012
- Suppression of Klotho expression by protein-bound uremic toxins is associated with increased DNA methyltransferase expression and DNA hypermethylationKidney International, 2012
- Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney DiseaseJAMA, 2011
- Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney diseaseKidney International, 2011
- Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitroKidney International, 2011
- Renal osteodystrophy in the first decade of the new millennium: Analysis of 630 bone biopsies in black and white patientsJournal of Bone and Mineral Research, 2010
- Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trialThe Lancet, 2010
- The emerging role of phosphate in vascular calcificationKidney International, 2009